Monday, March 27, 2023
  • English
  • Marathi
No Result
View All Result
Daily PRABHAT
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
    • Health
    • Lifestyle
    • Technology
    • Science
Daily PRABHAT
No Result
View All Result
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
Home International

‘Portrays incorrect picture’, MEA on reports of it asking Bharat Biotech to address COVID vaccine issues

by
11 months ago
in International
A A
‘Portrays incorrect picture’, MEA on reports of it asking Bharat Biotech to address COVID vaccine issues
Share on FacebookShare on Twitter

New Delhi [India], April 29 (ANI): The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO’s emergency use approval (EUA) nod for its COVID jab, “potrayed an incorrect picture.”

According to sources, there have been media reports purportedly quoting a communication from MEA to Dr VK Paul, Member, NITI Aayog.

“It appears that this refers to an internal document circulated to members of the Empowered Group-5, which comprehensively looks at all issues related to vaccines,” sources said on Friday.

“Selective parts of the communication have been highlighted out of context to portray an incorrect picture,” the MEA sources said.

The note, they said, only lists several issues in a factual manner for consideration of the Empowered Group and does not indicate MEA’s position or comment on any issue under consideration.

Earlier, the World Health Organization had said that it suspended supply of Covaxin through United Nations agencies in response to the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.

However, the UN body has clarified that there are no issues related to the safety and efficacy of the vaccine.

Later, MEA said this suspension will not have an impact on travel by those who have taken the COVID vaccine. (ANI)

ShareTweetSendShareSend

Latest News

BSP to contest Karnataka assembly elections, says Mayawati

Shilpa Shetty lists down benefits of aerobics

Check out how Samantha reacted when a Twitter user asked her to “date someone”

Radhika Madan’s ‘Sanaa’ to be screened at UK Asian Film Festival

“Seniors didn’t get their deserved respect”: Pakistan’s Shadab makes big statement following T20I series loss to Afghanistan

Transparent & good governance, inclusive Growth and opportunities for all mark the advent of New India under PM Modi: Union MoS Rajeev Chandrasekhar

JAIN (Deemed-to-be University) to host the Industry and Academia Confab (INAC) 2023 on the 11th and 12th of April 2023; register soon

The Durex Birds and Bees Talk Programme expands to Gujarat and Delhi aiming to transform 15 million adolescent lives

Star trio is back again

Parliament passes Finance Bill, Lok Sabha approves amended bill okayed by Rajya Sabha

New Delhi [India], April 29 (ANI): The Minstry of External Affairs has said that media reports purportedly quoting a communication from the ministry asking vaccine maker Bharat Biotech to address issues to avoid cancellation of WHO's emergency use approval (EUA) nod for its COVID jab, "potrayed an incorrect picture."

According to sources, there have been media reports purportedly quoting a communication from MEA to Dr VK Paul, Member, NITI Aayog.

"It appears that this refers to an internal document circulated to members of the Empowered Group-5, which comprehensively looks at all issues related to vaccines," sources said on Friday.

"Selective parts of the communication have been highlighted out of context to portray an incorrect picture," the MEA sources said.

The note, they said, only lists several issues in a factual manner for consideration of the Empowered Group and does not indicate MEA's position or comment on any issue under consideration.

Earlier, the World Health Organization had said that it suspended supply of Covaxin through United Nations agencies in response to the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.

However, the UN body has clarified that there are no issues related to the safety and efficacy of the vaccine.

Later, MEA said this suspension will not have an impact on travel by those who have taken the COVID vaccine. (ANI)

No Result
View All Result
  • Home
  • Latest News
  • National
  • International
  • Entertainment
  • Politics
  • Sports
  • Business
  • More
    • Health
    • Lifestyle
    • Technology
    • Science